Deformational changes after convection-enhanced delivery in the pediatric brainstem

被引:7
|
作者
Bander, Evan D. [1 ,2 ]
Tizi, Karima [3 ]
Wembacher-Schroeder, Eva [4 ]
Thomson, Rowena [4 ]
Donzelli, Maria [2 ]
Vasconcellos, Elizabeth [4 ]
Souweidane, Mark M. [1 ,2 ]
机构
[1] Cornell Univ, Dept Neurol Surg, Weill Med Coll, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurol Surg, 1275 York Ave, New York, NY 10021 USA
[3] Hop Univ Geneve, Dept Neurosurg, Geneva, Switzerland
[4] Brainlab AG, Munich, Germany
关键词
convection-enhanced delivery; deformation; volumetric; hydrocephalus; diffuse intrinsic pontine glioma; brainstem; INFUSION; GLIOMAS; LEAKAGE;
D O I
10.3171/2019.10.FOCUS19679
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE In the brainstem, there are concerns regarding volumetric alterations following convection-enhanced delivery (CED). The relationship between distribution volume and infusion volume is predictably greater than one. Whether this translates into deformational changes and influences clinical management is unknown. As part of a trial using CED for diffuse intrinsic pontine glioma (DIPG), the authors measured treatment-related volumetric alterations in the brainstem and ventricles. METHODS Enrolled patients underwent a single infusion of radioimmunotherapy. Between 2012 and 2019, 23 patients with volumetric pre- and postoperative day 1 (POD1) and day 30 (POD30) MRI scans were analyzed using iPlan (R) Flow software for semiautomated volumetric measurements of the ventricles and pontine segment of the brainstem. RESULTS Children in the study had a mean age of 7.7 years (range 2-18 years). The mean infusion volume was 3.9 +/- 1.7 ml (range 0.8-8.8 ml). Paired t-tests demonstrated a significant increase in pontine volume immediately following infusion (p < 0.0001), which trended back toward baseline by POD30 (p = 0.046; preoperative 27.6 +/- 8.4 ml, POD1 30.2 +/- 9.0 ml, POD30 29.5 +/- 9.4 ml). Lateral ventricle volume increased (p = 0.02) and remained elevated on POD30 (p = 0.04; preoperative 23.5 +/- 15.4 ml, POD1 26.3 +/- 16.0, POD30 28.6 +/- 21.2). Infusion volume had a weak, positive correlation with pontine and lateral ventricle volume change (r(2) = 0.22 and 0.27, respectively). Four of the 23 patients had an increase in preoperative neurological deficits at POD30. No patients required shunt placement within 90 days. CONCLUSIONS CED infusion into the brainstem correlates with immediate but self-limited deformation changes in the pons. The persistence of increased ventricular volume and no need for CSF diversion post-CED are inconsistent with obstructive hydrocephalus. Defining the degree and time course of these deformational changes can assist in the interpretation of neuroimaging along the DIPG disease continuum when CED is incorporated into the treatment algorithm.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] CONVECTION-ENHANCED DELIVERY OF MACROMOLECULES IN THE BRAIN
    BOBO, RH
    LASKE, DW
    AKBASAK, A
    MORRISON, PF
    DEDRICK, RL
    OLDFIELD, EH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2076 - 2080
  • [22] Convection-enhanced delivery of adenoviral vectors
    Idema, Sander
    Lamfers, Martine
    Van Beusechem, Victor
    Noske, David
    Dirven, Clemens
    Vandertop, W. Peter
    NEURO-ONCOLOGY, 2007, 9 (04) : 496 - 496
  • [23] Convection-Enhanced Delivery: Neurosurgical Issues
    Hall, W. A.
    CURRENT DRUG TARGETS, 2009, 10 (02) : 126 - 130
  • [24] Convection-enhanced delivery in the treatment of epilepsy
    Michael A. Rogawski
    Neurotherapeutics, 2009, 6 : 344 - 351
  • [25] Convection-enhanced delivery of nanomaterials for glioma
    Saltzman, Mark
    CANCER RESEARCH, 2017, 77
  • [26] Convection-Enhanced Delivery in the Treatment of Epilepsy
    Rogawski, Michael A.
    NEUROTHERAPEUTICS, 2009, 6 (02) : 344 - 351
  • [27] Convection-enhanced delivery for the treatment of glioblastoma
    Vogelbaum, Michael A.
    Aghi, Manish K.
    NEURO-ONCOLOGY, 2015, 17 : II3 - II8
  • [28] CONVECTION-ENHANCED DELIVERY IN THE TREATMENT OF GLIOBLASTOMA
    Brown, Casey B.
    Jacobs, Susanne
    Johnson, Mark P.
    Southerland, Cindy
    Threatt, Stevie
    SEMINARS IN ONCOLOGY NURSING, 2018, 34 (05) : 494 - 500
  • [29] CONVECTION-ENHANCED DELIVERY OF NANOLIPOSOMAL CPT-11 (IRINOTECAN) IN HUMAN BRAINSTEM GLIOMA XENOGRAFTS
    Hashizume, Rintaro
    Aoki, Yasuyuki
    Serwer, Laura P.
    Drummond, Daryl
    Noble, Charles
    Park, John
    Bankiewicz, Krystof
    James, David C.
    Gupta, Nalin
    NEURO-ONCOLOGY, 2010, 12 : 87 - 88
  • [30] Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma
    Saito, Ryuta
    Kanamori, Masayuki
    Sonoda, Yukihiko
    Yamashita, Yoji
    Nagamatsu, Kenichi
    Murata, Takaki
    Mugikura, Shunji
    Kumabe, Toshihiro
    Wembacher-Schroeder, Eva
    Thomson, Rowena
    Tominaga, Teiji
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)